STERIS plc – NYSE:STE
STERIS stock price today
$249.9
+41.92
+20.16%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 5 hours
STERIS stock price monthly change
-6.20%
month
STERIS stock price quarterly change
-6.20%
quarter
STERIS stock price yearly change
-6.88%
year
STERIS key metrics
Market Cap | 20.35B |
Enterprise value | 22.75B |
P/E | 47.29 |
EV/Sales | 4.19 |
EV/EBITDA | 16.92 |
Price/Sales | 3.78 |
Price/Book | 3.11 |
PEG ratio | -14.89 |
EPS | 3.83 |
Revenue | 5.22B |
EBITDA | 854.37M |
Income | 381.73M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 8.02% |
Oper. margin | 17.04% |
Gross margin | 44.34% |
EBIT margin | 17.04% |
EBITDA margin | 16.36% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSTERIS stock price history
STERIS stock forecast
STERIS financial statements
Average Price Target
$262.5
Potential upside: 5.04%
Analysts Price target
Financials & Ratios estimates
| Dec 2021 | 1.20B | 143.62M | 11.88% |
|---|---|---|---|
| Mar 2022 | 1.21B | 52.26M | 4.32% |
| Mar 2023 | 1.38B | 187.22M | 13.52% |
| Mar 2024 | 1.41B | -1.37M | -0.1% |
1.04%
Yield TTM
| Payout ratio | 48.4% |
|---|
| 2020 | 1.04% |
|---|---|
| 2021 | 0.82% |
| 2022 | 0.69% |
| 2023 | 0.96% |
| 2024 | 0.92% |
| Sep 2022 | 10489636000 | 4.67B | 44.58% |
|---|---|---|---|
| Dec 2022 | 10799924000 | 4.75B | 43.99% |
| Mar 2023 | 10821839000 | 4.73B | 43.75% |
| Mar 2024 | 11063697000 | 4.74B | 42.92% |
| Dec 2021 | 244.31M | -79.8M | -189.26M |
|---|---|---|---|
| Mar 2022 | 171.73M | 93.57M | -274.60M |
| Mar 2023 | 215.79M | -77.57M | -191.94M |
| Mar 2024 | 254.80M | -95.49M | -143.88M |
STERIS alternative data
| Sep 2023 | 17,000 |
|---|---|
| Oct 2023 | 17,000 |
| Nov 2023 | 17,000 |
| Dec 2023 | 17,000 |
| Jan 2024 | 17,000 |
| Feb 2024 | 17,000 |
| Mar 2024 | 17,000 |
| Apr 2024 | 17,000 |
| May 2024 | 17,000 |
| Jun 2024 | 18,000 |
| Jul 2024 | 18,000 |
STERIS other data
93.22%
+1.84%
of STE is owned by hedge funds
643
+15
91.66M
-477.30K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2024 | 0 | 45645 |
| Jun 2024 | 0 | 8184 |
| Aug 2024 | 0 | 473 |
| Sep 2024 | 0 | 46664 |
| Nov 2024 | 0 | 1682 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | MAJORS CARY L officer: SVP and .. | Ordinary Shares | 1,682 | $217.32 | $365,532 | ||
Option | TOKICH MICHAEL J officer: Sr. Vice.. | Ordinary Shares | 20,213 | $114.22 | $2,308,729 | ||
Sale | TOKICH MICHAEL J officer: Sr. Vice.. | Ordinary Shares | 10,316 | $243.53 | $2,512,255 | ||
Sale | TOKICH MICHAEL J officer: Sr. Vice.. | Ordinary Shares | 3,485 | $244.55 | $852,257 | ||
Sale | TOKICH MICHAEL J officer: Sr. Vice.. | Ordinary Shares | 5,985 | $245.79 | $1,471,053 | ||
Sale | TOKICH MICHAEL J officer: Sr. Vice.. | Ordinary Shares | 427 | $247.08 | $105,503 | ||
Option | TOKICH MICHAEL J officer: Sr. Vice.. | Employee Stock Option (right to buy) | 20,213 | $114.22 | $2,308,729 | ||
Option | TOKICH MICHAEL J officer: Sr. Vice.. | Ordinary Shares | 3,119 | $114.22 | $356,252 | ||
Sale | TOKICH MICHAEL J officer: Sr. Vice.. | Ordinary Shares | 3,119 | $248.02 | $773,574 | ||
Option | TOKICH MICHAEL J officer: Sr. Vice.. | Employee Stock Option (right to buy) | 3,119 | $114.22 | $356,252 |
| Quarter | Transcript |
|---|---|
| Q4 2024 9 May 2024 | Q4 2024 Earnings Call Transcript |
| Q3 2024 8 Feb 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 8 Nov 2023 | Q2 2024 Earnings Call Transcript |
| Q1 2024 2 Aug 2023 | Q1 2024 Earnings Call Transcript |
Sotera Health: A Great Business At A Discount
Becton, Dickinson and Company: Still Not Very Healthy
Steris: FCF Generation, No Supply Chain Risks, And Undervalued
Sotera Health Continues Capacity Expansion Efforts
Steris: Sotera Overhang Less Visible, Re-Rate To Buy
Sotera Health: Litigation Looms Large
Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Becton, Dickinson: Acquisitions Underwhelming
12 Top Stocks For A Bear Market - Automatic Data Processing Is Our Favorite
-
What's the price of STERIS stock today?
One share of STERIS stock can currently be purchased for approximately $249.9.
-
When is STERIS's next earnings date?
Unfortunately, STERIS's (STE) next earnings date is currently unknown.
-
Does STERIS pay dividends?
Yes, STERIS pays dividends and its trailing 12-month yield is 1.05% with 48% payout ratio. The last STERIS stock dividend of $0.43 was paid on 17 Dec 2021.
-
How much money does STERIS make?
STERIS has a market capitalization of 20.35B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.65% to 5.14B US dollars.
-
What is STERIS's stock symbol?
STERIS plc is traded on the NYSE under the ticker symbol "STE".
-
What is STERIS's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of STERIS?
Shares of STERIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are STERIS's key executives?
STERIS's management team includes the following people:
- Mr. Walter M. Rosebrough Jr. Chief Executive Officer Emeritus & Senior Advisor(age: 71, pay: $2,650,000)
- Mr. Daniel A. Carestio Pres, Chief Executive Officer & Director(age: 52, pay: $1,440,000)
- Mr. Michael J. Tokich Senior Vice President & Chief Financial Officer(age: 56, pay: $1,230,000)
- Mr. John Adam Zangerle Senior Vice President, Gen. Counsel, Sec.(age: 58, pay: $940,380)
- Mr. Cary L. Majors Senior Vice President of North America Commercial Operations(age: 50, pay: $851,270)
-
How many employees does STERIS have?
As Jul 2024, STERIS employs 18,000 workers, which is 6% more then previous quarter.
-
When STERIS went public?
STERIS plc is publicly traded company for more then 33 years since IPO on 1 Jun 1992.
-
What is STERIS's official website?
The official website for STERIS is steris.com.
-
How can i contact STERIS?
STERIS can be reached via phone at +353 1 232 2000.
-
What is STERIS stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for STERIS in the last 12 months, the avarage price target is $262.5. The average price target represents a 5.04% change from the last price of $249.9.
STERIS company profile:
STERIS plc
steris.comExchange:
NYSE
Full time employees:
18,000
Industry:
Medical - Devices
Sector:
Healthcare
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
70 Sir John Rogerson's Quay
Dublin, D02 R296
Dublin, D02 R296
CIK: 0001757898
ISIN: IE00BFY8C754
CUSIP: G8473T100
